{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T05:12:27Z","timestamp":1759641147466,"version":"build-2065373602"},"reference-count":191,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012353","name":"German Cancer Consortium","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012353","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National German Health Centers"},{"name":"ederal German Ministry of Education and Research"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.bbcan.2018.12.006","type":"journal-article","created":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T11:28:19Z","timestamp":1546255699000},"page":"126-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Modulation of radiation sensitivity and antitumor immunity by viral pathogenic factors: Implications for radio-immunotherapy"],"prefix":"10.1016","volume":"1871","author":[{"given":"Franz","family":"R\u00f6del","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8674-2683","authenticated-orcid":false,"given":"Daniel","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Balermpas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Wieland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ria","family":"Winkelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Riekmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Falk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"R\u00f6del","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouil","family":"Fokas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2018.12.006_bb0005","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","article-title":"Global burden of cancers attributable to infections in 2008: a review and synthetic analysis","volume":"13","author":"de Martel","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0010","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.chom.2014.02.011","article-title":"Human viral oncogenesis: a cancer hallmarks analysis","volume":"15","author":"Mesri","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0025","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1200\/JCO.2016.68.1478","article-title":"Antitumor activity of pembrolizumab in biomarker-unselected patients with recurrent and\/or metastatic head and neck squamous cell carcinoma: results from the phase Ib KEYNOTE-012 expansion cohort","volume":"34","author":"Chow","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0030","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/PPO.0000000000000180","article-title":"Immune checkpoint therapy in head and neck cancers","volume":"22","author":"Msaouel","year":"2016","journal-title":"Cancer J."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0035","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/nrc2961","article-title":"Why do viruses cause cancer? Highlights of the first century of human tumour virology","volume":"10","author":"Moore","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0040","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1073\/pnas.80.12.3812","article-title":"A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions","volume":"80","author":"Durst","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0045","doi-asserted-by":"crossref","first-page":"D571","DOI":"10.1093\/nar\/gks984","article-title":"The Papillomavirus Episteme: a central resource for papillomavirus sequence data and analysis","volume":"41","author":"Van Doorslaer","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0050","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/cncr.29992","article-title":"The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer","volume":"122","author":"Guo","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0055","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1473-3099(17)30653-9","article-title":"Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis","volume":"18","author":"Lin","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0060","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.virusres.2009.06.008","article-title":"Oncogenic activities of human papillomaviruses","volume":"143","author":"McLaughlin-Drubin","year":"2009","journal-title":"Virus Res."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.currproblcancer.2018.03.003","article-title":"HPV: Molecular pathways and targets","volume":"42","author":"Gupta","year":"2018","journal-title":"Curr. Probl. Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0070","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/0092-8674(90)90409-8","article-title":"The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53","volume":"63","author":"Scheffner","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0075","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/viro.1999.0106","article-title":"Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis","volume":"267","author":"Song","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0080","first-page":"4862","article-title":"Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis","volume":"63","author":"Riley","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0085","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2886","article-title":"Human papillomavirus oncoproteins: pathways to transformation","volume":"10","author":"Moody","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0090","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1200\/JCO.2005.02.6310","article-title":"Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study","volume":"23","author":"Keegan","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0095","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12250-015-3592-5","article-title":"The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma","volume":"30","author":"Tsang","year":"2015","journal-title":"Virol. Sin."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0100","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/313812a0","article-title":"Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells","volume":"313","author":"Yates","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2014.84","article-title":"Epstein-Barr virus latent genes","volume":"47","author":"Kang","year":"2015","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0110","first-page":"185","article-title":"Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma","volume":"4","author":"Zheng","year":"2007","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0115","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/jmv.20896","article-title":"Latent membrane protein 1 encoded by Epstein-Barr virus induces telomerase activity via p16INK4A\/Rb\/E2F1 and JNK signaling pathways","volume":"79","author":"Ding","year":"2007","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0120","doi-asserted-by":"crossref","first-page":"565","DOI":"10.7150\/ijbs.24562","article-title":"Epstein-Barr virus-encoded microRNAs as regulators in host immune responses","volume":"14","author":"Wang","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0166-3542(98)00044-8","article-title":"Summary of the II international symposium on cytomegalovirus","volume":"39","author":"de Jong","year":"1998","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6120111","article-title":"Viral oncology: molecular biology and pathogenesis","volume":"6","author":"Mui","year":"2017","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41579-018-0064-6","article-title":"Molecular mechanisms of viral oncogenesis in humans","author":"Krump","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0140","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/S0140-6736(02)11524-8","article-title":"Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer","volume":"360","author":"Harkins","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0145","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/01.ju.0000080263.46164.97","article-title":"High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma","volume":"170","author":"Samanta","year":"2003","journal-title":"J. Urol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0150","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/jmv.23820","article-title":"High prevalence of HCMV and viral load in tumor tissues and peripheral blood of glioblastoma multiforme patients","volume":"86","author":"dos Santos","year":"2014","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11010-014-2049-8","article-title":"Role of HCMV miR-UL70-3p and miR-UL148D in overcoming the cellular apoptosis","volume":"393","author":"Babu","year":"2014","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0160","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.canlet.2016.10.022","article-title":"Cytomegalovirus as an oncomodulatory agent in the progression of glioma","volume":"384","author":"Joseph","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0165","doi-asserted-by":"crossref","first-page":"11736","DOI":"10.1158\/0008-5472.CAN-06-2056","article-title":"Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies","volume":"66","author":"Martinive","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0170","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/09553008914552491","article-title":"The 5Rs of radiobiology","volume":"56","author":"Steel","year":"1989","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0175","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.radonc.2015.09.002","article-title":"Modulation of therapeutic sensitivity by human papillomavirus","volume":"116","author":"Swick","year":"2015","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0180","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.radonc.2013.03.013","article-title":"HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity","volume":"107","author":"Rieckmann","year":"2013","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0185","doi-asserted-by":"crossref","first-page":"26995","DOI":"10.18632\/oncotarget.4863","article-title":"DNA double strand break repair defect and sensitivity to poly ADP-ribose polymerase (PARP) inhibition in human papillomavirus 16-positive head and neck squamous cell carcinoma","volume":"6","author":"Weaver","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0190","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1158\/0008-5472.CAN-13-0587","article-title":"Enhanced radiation sensitivity in HPV-positive head and neck cancer","volume":"73","author":"Kimple","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0195","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2147\/OTT.S68235","article-title":"Cytotoxic effect of lapatinib is restricted to human papillomavirus-positive head and neck squamous cell carcinoma cell lines","volume":"8","author":"Fumagalli","year":"2015","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0200","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ijrobp.2009.03.004","article-title":"Radiation response in two HPV-infected head-and-neck cancer cell lines in comparison to a non-HPV-infected cell line and relationship to signaling through AKT","volume":"74","author":"Gupta","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0205","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1093\/emboj\/cdf443","article-title":"Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1","volume":"21","author":"Iftner","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0210","first-page":"209","article-title":"HPV-16 E6 oncoprotein impairs the fidelity of DNA end-joining via p53-dependent and -independent pathways","volume":"28","author":"Shin","year":"2006","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0215","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1158\/0008-5472.CAN-13-2479","article-title":"p16INK4a impairs homologous recombination-mediated DNA repair in human papillomavirus-positive head and neck tumors","volume":"74","author":"Dok","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0220","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/onc.2016.250","article-title":"TRIP12 as a mediator of human papillomavirus\/p16-related radiation enhancement effects","volume":"36","author":"Wang","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0225","article-title":"Subjugation of TGFbeta signaling by human Papilloma virus in head and neck squamous cell carcinoma shifts DNA repair from homologous recombination to alternative end-joining","author":"Liu","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0230","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1158\/1078-0432.CCR-11-2058","article-title":"Downregulation of SMG-1 in HPV-positive head and neck squamous cell carcinoma due to promoter hypermethylation correlates with improved survival","volume":"18","author":"Gubanova","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0235","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0360-3016(96)00448-8","article-title":"Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation","volume":"37","author":"DeWeese","year":"1997","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0240","first-page":"1709","article-title":"Inhibition of radiation-induced apoptosis by dexamethasone in cervical carcinoma cell lines depends upon increased HPV E6\/E7","volume":"82","author":"Kamradt","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0245","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.canlet.2016.05.032","article-title":"EBV-LMP1 suppresses the DNA damage response through DNA-PK\/AMPK signaling to promote radioresistance in nasopharyngeal carcinoma","volume":"380","author":"Lu","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0250","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1038\/onc.2009.258","article-title":"Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints","volume":"28","author":"Gruhne","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0255","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1038\/onc.2014.32","article-title":"Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy","volume":"33","author":"Xiao","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0260","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.18632\/oncotarget.3331","article-title":"EBV-LMP1 targeted DNAzyme enhances radiosensitivity by inhibiting tumor angiogenesis via the JNKs\/HIF-1 pathway in nasopharyngeal carcinoma","volume":"6","author":"Yang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024647","article-title":"Down-regulation of EBV-LMP1 radio-sensitizes nasal pharyngeal carcinoma cells via NF-kappaB regulated ATM expression","volume":"6","author":"Ma","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0270","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.canlet.2013.11.006","article-title":"Cancer stem-like cell characteristics induced by EB virus-encoded LMP1 contribute to radioresistance in nasopharyngeal carcinoma by suppressing the p53-mediated apoptosis pathway","volume":"344","author":"Yang","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0275","first-page":"4507","article-title":"Epstein-Barr virus-encoded LMP1 increases miR-155 expression, which promotes radioresistance of nasopharyngeal carcinoma via suppressing UBQLN1","volume":"19","author":"Yang","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0280","doi-asserted-by":"crossref","first-page":"20297","DOI":"10.18632\/oncotarget.15526","article-title":"Epstein-Barr virus encoded microRNA BART7 regulates radiation sensitivity of nasopharyngeal carcinoma","volume":"8","author":"Gao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0285","doi-asserted-by":"crossref","first-page":"8479","DOI":"10.1073\/pnas.90.18.8479","article-title":"Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death","volume":"90","author":"Henderson","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0290","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3390\/cancers2020420","article-title":"Modulation of radiation-induced genetic damage by HCMV in peripheral blood lymphocytes from a brain tumor case-control study","volume":"2","author":"Rourke","year":"2010","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0295","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0300","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/ncb3015","article-title":"The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis","volume":"16","author":"McAllister","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0305","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrc3245","article-title":"The immune contexture in human tumours: impact on clinical outcome","volume":"12","author":"Fridman","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0310","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1172\/JCI32136","article-title":"Harnessing the immune system to treat cancer","volume":"117","author":"Bhardwaj","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0315","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0320","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.humimm.2009.02.008","article-title":"Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation","volume":"70","author":"Mantovani","year":"2009","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0325","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","article-title":"Myeloid-derived suppressor cells coming of age","volume":"19","author":"Veglia","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0330","doi-asserted-by":"crossref","first-page":"13119","DOI":"10.1073\/pnas.93.23.13119","article-title":"Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses","volume":"93","author":"Otsuji","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0335","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0340","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1874357901206010249","article-title":"The invisible enemy - how human papillomaviruses avoid recognition and clearance by the host immune system","volume":"6","author":"Grabowska","year":"2012","journal-title":"Open Virol. J."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0345","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11357-017-9986-6","article-title":"CMV immune evasion and manipulation of the immune system with aging","volume":"39","author":"Jackson","year":"2017","journal-title":"Geroscience"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0350","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/ijc.31027","article-title":"Immune evasion mechanisms of human papillomavirus: an update","volume":"142","author":"Steinbach","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006211","article-title":"The role of integration in oncogenic progression of HPV-associated cancers","volume":"13","author":"McBride","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0360","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ijc.20558","article-title":"E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I","volume":"113","author":"Ashrafi","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0365","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0165-2478(99)00170-4","article-title":"HPV type 16 protein E7 HLA-A2 binding peptides are immunogenic but not processed and presented","volume":"71","author":"Bauer","year":"2000","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0370","first-page":"333","article-title":"Cytomegalovirus immune evasion","volume":"325","author":"Powers","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0375","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00430-012-0257-y","article-title":"Murine cytomegalovirus immune evasion proteins operative in the MHC class I pathway of antigen processing and presentation: state of knowledge, revisions, and questions","volume":"201","author":"Lemmermann","year":"2012","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0380","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1126\/science.1088902","article-title":"Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1","volume":"301","author":"Yin","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0385","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/sj.onc.1209950","article-title":"Viral oncoproteins target the DNA methyltransferases","volume":"26","author":"Burgers","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0390","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00270-16","article-title":"Suppression of antitumor immune responses by human papillomavirus through epigenetic downregulation of CXCL14","volume":"7","author":"Cicchini","year":"2016","journal-title":"MBio"},{"issue":"Suppl. 3","key":"10.1016\/j.bbcan.2018.12.006_bb0395","article-title":"Chapter 1: HPV in the etiology of human cancer","volume":"24","author":"Munoz","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0400","doi-asserted-by":"crossref","first-page":"11396","DOI":"10.1128\/JVI.02151-15","article-title":"Downregulation of Toll-like receptor 9 expression by beta human papillomavirus 38 and implications for cell cycle control","volume":"89","author":"Pacini","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0405","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1089\/vim.2016.0103","article-title":"Role of TLR9 in oncogenic virus-produced cancer","volume":"30","author":"Martinez-Campos","year":"2017","journal-title":"Viral Immunol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0410","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1006\/viro.2000.0584","article-title":"The human papillomavirus E7 protein is able to inhibit the antiviral and anti-growth functions of interferon-alpha","volume":"277","author":"Barnard","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0415","doi-asserted-by":"crossref","first-page":"6764","DOI":"10.1074\/jbc.275.10.6764","article-title":"Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis","volume":"275","author":"Park","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0420","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1126\/science.aab3291","article-title":"DNA tumor virus oncogenes antagonize the cGAS-STING DNA-sensing pathway","volume":"350","author":"Lau","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091473","article-title":"E2 proteins of high risk human papillomaviruses down-modulate STING and IFN-kappa transcription in keratinocytes","volume":"9","author":"Sunthamala","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0430","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.1229963","article-title":"Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA","volume":"339","author":"Wu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0435","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.molcel.2014.03.040","article-title":"The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling","volume":"54","author":"Cai","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0440","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","article-title":"STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors","volume":"41","author":"Deng","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0445","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3109\/08830189809043004","article-title":"The concept of type-1 and type-2 helper T cells and their cytokines in humans","volume":"16","author":"Del Prete","year":"1998","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0450","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3892\/ol.2015.3295","article-title":"Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer","volume":"10","author":"Song","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0455","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0460","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc.2016.36","article-title":"Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy","volume":"16","author":"Topalian","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0465","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3892\/mmr.2017.6102","article-title":"Increased expression of PDL1 by the human papillomavirus 16 E7 oncoprotein inhibits anticancer immunity","volume":"15","author":"Liu","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0475","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1182\/blood.V86.7.2789.bloodjournal8672789","article-title":"Epstein-Barr virus modulates de novo protein synthesis in human neutrophils","volume":"86","author":"Beaulieu","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0480","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.4049\/jimmunol.159.12.6164","article-title":"EBV induces the production and release of IL-8 and macrophage inflammatory protein-1 alpha in human neutrophils","volume":"159","author":"McColl","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0485","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1182\/blood.V92.1.291.413k34_291_299","article-title":"Epstein-Barr virus infects and induces apoptosis in human neutrophils","volume":"92","author":"Larochelle","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0490","doi-asserted-by":"crossref","first-page":"24148","DOI":"10.1074\/jbc.M109036200","article-title":"Impaired protein kinase C activation\/translocation in Epstein-Barr virus-infected monocytes","volume":"277","author":"Tardif","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0495","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/eji.1830210130","article-title":"Inhibition of tumor necrosis factor-alpha transcription by Epstein-Barr virus","volume":"21","author":"Gosselin","year":"1991","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0500","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.4049\/jimmunol.170.12.6183","article-title":"Regulatory T cells secreting IL-10 dominate the immune response to EBV latent membrane protein 1","volume":"170","author":"Marshall","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0505","doi-asserted-by":"crossref","first-page":"E6467","DOI":"10.1073\/pnas.1605884113","article-title":"Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells","volume":"113","author":"Albanese","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0510","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.7150\/ijbs.19531","article-title":"Pathogenic role of exosomes in Epstein-Barr Virus (EBV)-associated cancers","volume":"13","author":"Teow","year":"2017","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0515","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1016\/j.jmb.2013.08.023","article-title":"The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus","volume":"425","author":"Amsler","year":"2013","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0520","doi-asserted-by":"crossref","DOI":"10.3390\/v9090249","article-title":"Die another day: inhibition of cell death pathways by cytomegalovirus","volume":"9","author":"Brune","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0525","doi-asserted-by":"crossref","DOI":"10.3390\/v8060156","article-title":"The role of microRNAs in the pathogenesis of herpesvirus infection","volume":"8","author":"Piedade","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0530","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.3390\/v4112448","article-title":"Human cytomegalovirus encoded homologs of cytokines, chemokines and their receptors: roles in immunomodulation","volume":"4","author":"McSharry","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0535","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1128\/JVI.02173-07","article-title":"Immunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infection","volume":"82","author":"Jenkins","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0540","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1055-9965.EPI-04-0551","article-title":"Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review","volume":"14","author":"Kreimer","year":"2005","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0545","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1021\/tx500034c","article-title":"Prevalence of human papillomavirus in oropharyngeal squamous cell carcinoma in the United States across time","volume":"27","author":"Stein","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0550","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.semradonc.2011.12.004","article-title":"Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma","volume":"22","author":"Ang","year":"2012","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0555","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.radonc.2014.11.011","volume":"113","author":"Lohaus","year":"2014","journal-title":"Radiother Oncol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0560","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/ijc.22851","article-title":"Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis","volume":"121","author":"Ragin","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0565","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1470-2045(17)30246-2","article-title":"Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study","volume":"18","author":"Chen","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0570","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.ijrobp.2013.08.029","article-title":"Review of the clinical and biologic aspects of human papillomavirus-positive squamous cell carcinomas of the head and neck","volume":"88","author":"Blitzer","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0575","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejca.2016.08.012","article-title":"CD8(+) T cell response to human papillomavirus 16 E7 is able to predict survival outcome in oropharyngeal cancer","volume":"67","author":"Masterson","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0580","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/annonc\/mdr006","article-title":"Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial","volume":"22","author":"Posner","year":"2011","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0585","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/(SICI)1096-9896(199612)180:4<378::AID-PATH697>3.0.CO;2-H","article-title":"Properties of HPV-positive and HPV-negative anal carcinomas","volume":"180","author":"Williams","year":"1996","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0590","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.radonc.2014.11.013","article-title":"Influence of human papillomavirus and p16(INK4a) on treatment outcome of patients with anal cancer","volume":"113","author":"Koerber","year":"2014","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0595","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/ijc.25825","article-title":"The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy","volume":"129","author":"Yhim","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0600","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1200\/JCO.2013.52.3464","article-title":"Human papillomavirus genotyping and p16 expression as prognostic factors for patients with American Joint Committee on Cancer stages I to III carcinoma of the anal canal","volume":"32","author":"Serup-Hansen","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0605","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00345-018-2280-0","article-title":"The relationship between HPV status and chemoradiotherapy in the locoregional control of penile cancer","volume":"36","author":"Yuan","year":"2018","journal-title":"World J. Urol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0610","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/ijc.30523","article-title":"HPV status and favourable outcome in vulvar squamous cancer","volume":"140","author":"Wakeham","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0615","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ijc.28979","article-title":"Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy","volume":"136","author":"Rodel","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0620","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ejca.2015.01.058","article-title":"High-sensitivity human Papilloma virus genotyping reveals near universal positivity in anal squamous cell carcinoma: different implications for vaccine prevention and prognosis","volume":"51","author":"Baricevic","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0625","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ygyno.2017.11.034","article-title":"Impact of HPV 16\/18 infection on clinical outcomes in locally advanced cervical cancers treated with radical radio (chemo) therapy - A prospective observational study","volume":"148","author":"Mahantshetty","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0630","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s10620-009-0812-6","article-title":"Molecular biomarkers correlate with disease-free survival in patients with anal canal carcinoma treated with chemoradiation","volume":"55","author":"Ajani","year":"2010","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0635","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/sj.bjc.6604285","article-title":"Gene expression reveals two distinct groups of anal carcinomas with clinical implications","volume":"98","author":"Bruland","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0640","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108790","article-title":"The prognostic value of HPV status and p16 expression in patients with carcinoma of the anal canal","volume":"9","author":"Roldan Urgoiti","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0645","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/bjc.2015.20","article-title":"HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53","volume":"112","author":"Meulendijks","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0650","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.ijrobp.2015.08.004","article-title":"Prognostic relevance of HPV infection and p16 overexpression in squamous cell anal cancer","volume":"93","author":"Mai","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0655","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.virol.2008.10.004","article-title":"Interaction of human papillomaviruses with the host immune system: a well evolved relationship","volume":"384","author":"Frazer","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0660","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1200\/JCO.2014.57.8435","article-title":"Human papillomavirus antibodies and future risk of anogenital cancer: a nested case-control study in the European prospective investigation into cancer and nutrition study","volume":"33","author":"Kreimer","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0665","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1200\/JCO.2012.47.2738","article-title":"Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer","volume":"31","author":"Kreimer","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0670","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1002\/ijc.30697","article-title":"Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma","volume":"140","author":"Holzinger","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0675","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3233\/CBM-160071","article-title":"Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinoma","volume":"19","author":"Hanna","year":"2017","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0680","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1158\/1940-6207.CAPR-15-0299","article-title":"Serum antibodies to HPV16 early proteins warrant investigation as potential biomarkers for risk stratification and recurrence of HPV-associated oropharyngeal cancer","volume":"9","author":"Fakhry","year":"2016","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0685","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1002\/cncr.30966","article-title":"Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence","volume":"123","author":"Lang Kuhs","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0690","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1158\/1078-0432.CCR-14-3323","article-title":"HPV serum antibodies as predictors of survival and disease progression in patients with HPV-positive squamous cell carcinoma of the oropharynx","volume":"21","author":"Dahlstrom","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0695","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/path.1490","article-title":"Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16\/18 and numerical chromosome abnormalities","volume":"202","author":"Hopman","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0700","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-18-0922","article-title":"Prognostic impact of residual HPV ctDNA detection after chemoradiotherapy for anal squamous cell carcinoma","author":"Cabel","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0705","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/ijc.30863","article-title":"HPV circulating tumor DNA to monitor the efficacy of anti-PD-1 therapy in metastatic squamous cell carcinoma of the anal canal: a case report","volume":"141","author":"Cabel","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0710","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/bjc.2017.258","article-title":"Predicting response to radical (chemo)radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma","volume":"117","author":"Lee","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0715","first-page":"1268","article-title":"The predictive value of pre- and post-induction chemotherapy plasma EBV DNA level and tumor volume for the radiosensitivity of locally advanced nasopharyngeal carcinoma","volume":"16","author":"Song","year":"2017","journal-title":"EXCLI J."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0720","doi-asserted-by":"crossref","first-page":"e5130","DOI":"10.1097\/MD.0000000000005130","article-title":"Epstein-Barr virus DNA level as a novel prognostic factor in nasopharyngeal carcinoma: A meta-analysis","volume":"95","author":"Zhang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0725","doi-asserted-by":"crossref","first-page":"24208","DOI":"10.18632\/oncotarget.8144","article-title":"Survival analysis of patients with advanced-stage nasopharyngeal carcinoma according to the Epstein-Barr virus status","volume":"7","author":"Peng","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0730","article-title":"Prognostic value of plasma epstein-barr virus DNA for local and regionally advanced nasopharyngeal carcinoma treated with cisplatin-based Concurrent chemoradiotherapy in intensity-modulated radiotherapy era","volume":"95","author":"Chen","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0735","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1111\/cas.13296","article-title":"Prognostic value of serum Epstein-Barr virus antibodies in patients with nasopharyngeal carcinoma and undetectable pretreatment Epstein-Barr virus DNA","volume":"108","author":"Yao","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0740","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3389\/fimmu.2017.01225","article-title":"Peripheral leukocytosis is Inversely correlated with intratumoral CD8+ T-cell infiltration and associated with worse outcome after chemoradiotherapy in anal cancer","volume":"8","author":"Martin","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0745","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1470-2045(15)70126-9","article-title":"Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis","volume":"16","author":"Blanchard","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0750","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.virol.2010.10.029","article-title":"Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin","volume":"410","author":"Lu","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0755","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.3892\/or.2015.3847","article-title":"LMP-1 induces survivin expression to inhibit cell apoptosis through the NF-kappaB and PI3K\/Akt signaling pathways in nasal NK\/T-cell lymphoma","volume":"33","author":"Sun","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0760","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/092986711794088362","article-title":"The role of survivin for radiation oncology: moving beyond apoptosis inhibition","volume":"18","author":"Rodel","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0765","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/jclinpath-2011-200198","article-title":"LMP1 expression is positively associated with metastasis of nasopharyngeal carcinoma: evidence from a meta-analysis","volume":"65","author":"Zhao","year":"2012","journal-title":"J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.bbcan.2018.12.006_bb0770","article-title":"Low levels of Human Cytomegalovirus Infection in Glioblastoma multiforme associates with patient survival; \u2212a case-control study","volume":"3","author":"Rahbar","year":"2012","journal-title":"Herpesviridae"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0775","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jcv.2012.12.018","article-title":"Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival","volume":"57","author":"Rahbar","year":"2013","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0780","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00066-016-0987-7","article-title":"Clinically significant CMV (re)activation during or after radiotherapy\/chemotherapy of the brain: Correlation with neurological deterioration and improvement upon antiviral treatment","volume":"192","author":"Goerig","year":"2016","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0785","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1158\/1078-0432.CCR-16-2057","article-title":"Long-term survival in glioblastoma with cytomegalovirus pp65-targeted vaccination","volume":"23","author":"Batich","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0790","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1158\/1078-0432.CCR-17-2140","article-title":"Intratumoral HPV16-specific T cells constitute a type I-oriented tumor microenvironment to improve survival in HPV16-driven oropharyngeal cancer","volume":"24","author":"Welters","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0795","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fonc.2012.00095","article-title":"Role of T lymphocytes in tumor response to radiotherapy","volume":"2","author":"Demaria","year":"2012","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0800","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1158\/1078-0432.CCR-14-2481","article-title":"Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes","volume":"21","author":"Keck","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0805","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ijrobp.2009.02.015","article-title":"The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas","volume":"74","author":"Kong","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0810","doi-asserted-by":"crossref","DOI":"10.4161\/onci.27403","article-title":"Tumor-infiltrating lymphocytes favor the response to chemoradiotherapy of head and neck cancer","volume":"3","author":"Balermpas","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0815","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/bjc.2013.640","article-title":"Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer","volume":"110","author":"Balermpas","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0820","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ijc.29683","article-title":"CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG)","volume":"138","author":"Balermpas","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0825","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/bjc.2011.189","article-title":"The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis","volume":"105","author":"Gooden","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0830","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/bjc.2016.166","article-title":"Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer","volume":"115","author":"Sridharan","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0835","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.molimm.2018.02.005","article-title":"Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis","volume":"96","author":"Chen","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0840","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2018.01.008","article-title":"Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments","author":"Solomon","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0845","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1158\/0008-5472.CAN-12-2606","article-title":"PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer","volume":"73","author":"Badoual","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0850","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ijc.30770","article-title":"The PD-1\/PD-L1 axis and human Papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)","volume":"141","author":"Balermpas","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0855","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0860","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1470-2045(16)30066-3","article-title":"Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial","volume":"17","author":"Seiwert","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0865","first-page":"221","article-title":"The immune microenvironment and HPV in anal cancer: Rationale to complement chemoradiation with immunotherapy","volume":"1868","author":"Martin","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0870","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/bjc.2015.448","article-title":"Tumour-infiltrating lymphocyte scores effectively stratify outcomes over and above p16 post chemo-radiotherapy in anal cancer","volume":"114","author":"Gilbert","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0875","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1288331","article-title":"Human Papilloma virus load and PD-1\/PD-L1, CD8(+) and FOXP3 in anal cancer patients treated with chemoradiotherapy: Rationale for immunotherapy","volume":"6","author":"Balermpas","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0880","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/jso.23998","article-title":"Tumor-infiltrating CD8(+) T lymphocytes associated with clinical outcome in anal squamous cell carcinoma","volume":"112","author":"Hu","year":"2015","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0885","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CMAR.S153965","article-title":"Programmed death-ligand 1 expression correlates with diminished CD8+ T cell infiltration and predicts poor prognosis in anal squamous cell carcinoma patients","volume":"10","author":"Zhao","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0890","article-title":"Programmed cell death-ligand 1 (PD-L1) expression in anal cancer","author":"Govindarajan","year":"2016","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0895","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.oraloncology.2017.05.015","article-title":"Prognostic role of tumor infiltrating lymphocytes in EBV positive and EBV negative nasopharyngeal carcinoma","volume":"71","author":"Ooft","year":"2017","journal-title":"Oral Oncol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0900","article-title":"Prognostic role of tumour-associated macrophages and regulatory T cells in EBV-positive and EBV-negative nasopharyngeal carcinoma","author":"Ooft","year":"2017","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0905","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0910","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2217\/imt.14.38","article-title":"Kill and spread the word: stimulation of antitumor immune responses in the context of radiotherapy","volume":"6","author":"Gaipl","year":"2014","journal-title":"Immunotherapy"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0915","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.1016\/S1470-2045(15)00007-8","article-title":"Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy","volume":"16","author":"Sharabi","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0920","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/jamaoncol.2015.2756","article-title":"Role of local radiation therapy in cancer immunotherapy","volume":"1","author":"Demaria","year":"2015","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0925","first-page":"58","article-title":"Candidate immune biomarkers for radioimmunotherapy","volume":"1868","author":"Levy","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbcan.2018.12.006_bb0930","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1158\/0008-5472.CAN-15-0255","article-title":"Classifying cancers based on T-cell infiltration and PD-L1","volume":"75","author":"Teng","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0935","doi-asserted-by":"crossref","first-page":"127ra137","DOI":"10.1126\/scitranslmed.3003689","article-title":"Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape","volume":"4","author":"Taube","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0940","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1158\/1078-0432.CCR-15-2834","article-title":"Pan-cancer immunogenomic perspective on the tumor microenvironment based on PD-L1 and CD8 T-cell infiltration","volume":"22","author":"Ock","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0945","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.ijrobp.2018.01.004","article-title":"Tolerability of ADXS11\u2013001 Lm-LLO listeria-based immunotherapy with mitomycin, fluorouracil, and radiation for anal cancer","volume":"100","author":"Safran","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0950","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1158\/2326-6066.CIR-14-0015","article-title":"Oncolytic viruses and their application to cancer immunotherapy","volume":"2","author":"Chiocca","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0955","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/mt.2015.115","article-title":"Viral infection of tumors overcomes resistance to PD-1-immunotherapy by broadening neoantigenome-directed T-cell responses","volume":"23","author":"Woller","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbcan.2018.12.006_bb0960","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/imr.12572","article-title":"Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases","volume":"280","author":"Frey","year":"2017","journal-title":"Immunol. Rev."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X18301653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X18301653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:28:29Z","timestamp":1759638509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X18301653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":191,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0304419X18301653"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2018.12.006","relation":{},"ISSN":["0304-419X"],"issn-type":[{"type":"print","value":"0304-419X"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of radiation sensitivity and antitumor immunity by viral pathogenic factors: Implications for radio-immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2018.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}